Invest in IGM Biosciences Inc. (IGMS) to keep your portfolio healthy

After finishing at $21.18 in the prior trading day, IGM Biosciences Inc. (NASDAQ: IGMS) closed at $22.10, up 4.34%. In other words, the price has increased by $+0.92 from its previous closing price. On the day, 224727 shares were traded. IGMS stock price reached its highest trading level at $22.44 during the session, while it also had its lowest trading level at $20.74.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of IGMS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.80 and its Current Ratio is at 10.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On October 17, 2022, JP Morgan started tracking the stock assigning a Neutral rating and target price of $27.

On August 29, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $34.BofA Securities initiated its Buy rating on August 29, 2022, with a $34 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 08 when BEHRENS M KATHLEEN bought 60,000 shares for $17.14 per share. The transaction valued at 1,028,550 led to the insider holds 218,200 shares of the business.

Keyt Bruce sold 25,000 shares of IGMS for $570,980 on Oct 04. The Chief Scientific Officer now owns 39,489 shares after completing the transaction at $22.84 per share. On Sep 29, another insider, LOBERG MICHAEL D, who serves as the Director of the company, bought 5,821 shares for $19.62 each. As a result, the insider paid 114,213 and bolstered with 35,305 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1409.66 while its Price-to-Book (P/B) ratio in mrq is 2.97.

Stock Price History:

Over the past 52 weeks, IGMS has reached a high of $56.41, while it has fallen to a 52-week low of $12.67. The 50-Day Moving Average of the stock is 20.57, while the 200-Day Moving Average is calculated to be 18.96.

Shares Statistics:

The stock has traded on average 219.12K shares per day over the past 3-months and 397.97k shares per day over the last 10 days, according to various share statistics. A total of 44.03M shares are outstanding, with a floating share count of 17.95M. Insiders hold about 1.10% of the company’s shares, while institutions hold 61.60% stake in the company. Shares short for IGMS as of Oct 13, 2022 were 3.45M with a Short Ratio of 3.37M, compared to 3.22M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.08% and a Short% of Float of 30.01%.

Earnings Estimates

Its stock is currently analyzed by 11 different market analysts. On average, analysts expect EPS of -$1.43 for the current quarter, with a high estimate of -$1.14 and a low estimate of -$1.53, while EPS last year was -$1.32. The consensus estimate for the next quarter is -$1.27, with high estimates of $1.47 and low estimates of -$1.69.

Analysts are recommending an EPS of between -$2.41 and -$6.04 for the fiscal current year, implying an average EPS of -$5.44. EPS for the following year is -$5.46, with 10 analysts recommending between -$3.01 and -$6.78.